CARBIZOLE 20 Carbimazole (20mg) Carbimazole is a medication used in the treatment of hyperthyroidism, a condition characterized by an overactive thyroid gland. It is particularly prescribed for individuals with Graves' disease, an autoimmune disorder that leads to excessive production of thyroid hormones. Here are some key points about Carbimazole: Indications: Carbimazole is indicated for the management of hyperthyroidism, including Graves' disease and toxic nodular goiter. Mechanism of Action: Carbimazole works by inhibiting the production of thyroid hormones, primarily thyroxine (T4), by interfering with the function of an enzyme called thyroid peroxidase. This enzyme is crucial for the synthesis of thyroid hormones. Dosage: The dosage of Carbimazole is usually determined based on the severity of hyperthyroidism and the individual patient's response. It is typically taken orally. Initiation and Maintenance: Treatment with Carbimazole often begins with a higher dose (titration phase) to quickly bring thyroid hormone levels under control. This is followed by a maintenance dose to keep the thyroid function within the normal range. Monitoring: Regular monitoring of thyroid function, including levels of thyroid-stimulating hormone (TSH), free thyroxine (FT4), and free triiodothyronine (FT3), is essential during Carbimazole therapy to adjust the dosage as needed. Side Effects: Common side effects may include gastrointestinal symptoms (nausea, vomiting), skin rash, and joint pain. Serious side effects are rare but can include agranulocytosis (a significant reduction in white blood cell count), which requires immediate medical attention. Contraindications: Carbimazole is generally contraindicated in individuals with a known hypersensitivity to the drug and in patients with aplastic anemia or agranulocytosis associated with prior use of thionamide drugs. Pregnancy and Breastfeeding: Carbimazole may be used cautiously during pregnancy, especially in the first trimester, and breastfeeding is generally not recommended during active treatment. Duration of Treatment: The duration of Carbimazole treatment varies among individuals and is often determined by the underlying cause of hyperthyroidism. In some cases, other treatment options such as radioactive iodine therapy or surgery may be considered. As with any medication, the information provided here is general, and specific details about the use of Carbimazole should be discussed with a healthcare professional. The decision to use Carbimazole, as well as the dosage and treatment plan, will depend on individual factors, including the type and severity of hyperthyroidism and the patient's overall health. Regular follow-up with a healthcare provider is crucial to monitor the response to treatment and adjust the dosage as needed. Steris Healthcare Pvt. Ltd. is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week we have a new product in our portfolio. In Last 4 years we are dealing in Chronic Therapy and in 4 years we grow by 200% Annually, because we deal in high quality medicine. Steris medicine manufactures at WHO-GMP Approved Plants & We have Legal manufacturing contracts with all leading manufacturers of India. Today we have 1000+ Business Franchise Partners in PAN India. Steris's medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with a similar pace with the STERIS. Be first to launch like us. For further information please contact: contact@sterispharma.com https://www.sterisonline.com/product/carbizole-20-133894